Display Settings:

Format

Send to:

Choose Destination
    J Neuroimmunol. 2010 Oct 8;227(1-2):71-9. Epub 2010 Jul 15.

    Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2.

    Source

    Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA.

    Abstract

    Glatiramer acetate (GA) is an immunomodulator approved for therapy of relapsing-remitting multiple sclerosis (RRMS), but recent findings indicate that it may also have additional, neurotrophic effects. Here, we found that supernatants from human GA-reactive T lymphocytes potentiated oligodendrocyte numbers in rodent and human oligodendrocyte progenitor (OPC) cultures. Effects of Th2-polarized lines were stronger than Th1-polarized cells. Microarray and ELISA analyses revealed that neurotrophic factors induced in Th2- and Th1-polarized GA-reactive lines included IGF-2 and BMP-7 respectively, and functional studies confirmed IGF-2 as trophic for OPCs. Our results support the concept that GA therapy may result in supportive effects on oligodendrocytes in RRMS patients.

    Copyright © 2010 Elsevier B.V. All rights reserved.

    PMID:
    20637510
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2943020
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Figure 1
    Figure 3
    Figure 5
    Figure 2
    Figure 4

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk